Role of ACE/ARB inhibitors in the treatment of COVID-19
A new opinion piece published in the journal Circulation Research in April 2020 defends the use of antihypertensive drugs called ACE inhibitors and ARBs in patients with pandemic viral pneumonia called COVID-19.
No hay comentarios:
Publicar un comentario